Early preemptive immunomodulators (corticosteroids) for severe pneumonia patients infected with SARS-CoV-2
Open Access
- 15 April 2020
- journal article
- editorial
- Published by Korean Pediatric Society in Clinical and Experimental Pediatrics
- Vol. 63 (4), 117-118
- https://doi.org/10.3345/cep.2020.00290
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Early Corticosteroid Therapy for Mycoplasma pneumoniae Pneumonia Irrespective of Used Antibiotics in ChildrenJournal of Clinical Medicine, 2019
- Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of MortalityEBioMedicine, 2017
- A unified pathogenesis for kidney diseases, including genetic diseases and cancers, by the protein-homeostasis-system hypothesisKidney Research and Clinical Practice, 2017
- Pneumonia, Acute Respiratory Distress Syndrome, and Early Immune-Modulator TherapyInternational Journal of Molecular Sciences, 2017
- A Common Immunopathogenesis Mechanism for Infectious Diseases: The Protein-Homeostasis-System HypothesisInfection & Chemotherapy, 2015
- Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory commentsBMJ, 2014
- Epidemiological and clinical characteristics of childhood pandemic 2009 H1N1 virus infection: an observational cohort studyBMC Infectious Diseases, 2011
- Hyperactive immune cells (T cells) may be responsible for acute lung injury in influenza virus infections: A need for early immune-modulators for severe casesMedical Hypotheses, 2011
- TLRs and innate immunityBlood, 2009
- The Danger Model: A Renewed Sense of SelfScience, 2002